Related Experiment Videos

Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst

R Coello1, J R Glynn, C Gaspar

  • 1Servicio de Medicina Preventiva, Hospital Universitario San Carlos, Madrid, Spain.

Insights

Hospitalized patients colonized with methicillin-resistant Staphylococcus aureus (MRSA) face infection risks. Intensive care, wounds, and catheters increase MRSA infection rates, suggesting targeted prevention for high-risk groups.

Area of Science:

  • Infectious Diseases
  • Hospital Epidemiology
  • Clinical Microbiology

Background:

  • Hospital outbreaks of methicillin-resistant Staphylococcus aureus (MRSA) frequently involve patient colonization without active infection.
  • The transition from MRSA colonization to clinical infection remains poorly understood.
  • Identifying risk factors for MRSA infection progression is crucial for effective patient management.

Purpose of the Study:

  • To prospectively identify risk factors associated with the development of MRSA infection in hospitalized patients initially colonized with MRSA.
  • To inform targeted prevention strategies during MRSA outbreaks.

Main Methods:

  • A cohort of 479 MRSA-colonized patients was followed prospectively.
  • Cox proportional hazards survival analysis was used to assess risk factors for MRSA infection.
  • Multivariate analysis identified independent predictors of MRSA infection.

Main Results:

  • 11.1% of patients developed MRSA infections.
  • Intensive care setting, multiple antibiotic use, ulcers, surgical wounds, invasive devices (tubes, drains, catheters) were associated with increased MRSA infection rates.
  • Independent risk factors included intensive care (HR 26.9), surgical wounds (HR 2.9), pressure ulcers (HR 3.0), and IV catheterization (HR 4.7).

Conclusions:

  • Intensive care and surgical patients require priority for MRSA colonization prevention.
  • Preventing pressure ulcers and maintaining aseptic care for wounds and catheters can reduce MRSA infection.
  • MRSA-colonized patients with risk factors may benefit from early empirical vancomycin therapy.

Related Concept Videos